Michelle Yong
@michyong2
Followers
1K
Following
5K
Statuses
723
ID physician, CMV & viral infections, Clinician researcher, @NCICancer @PeterMacCC @TheRMH @TheDohertyInst
Melbourne, Victoria
Joined September 2017
Starting now @NCICancer Fungal Symposium with Prof Kontoyiannis speaking! A difficult case with proptosis with fungal elements. I know it’s Halloween in the US but having Dimitrios speak is a real treat ! 👻🎃@NCICancer @PergamIC @JulianLindsay_ @IchsGlobal @monicaslavin
Final Countdown ⏰: Just 3 days to the Annual NCIC Symposium! Join us in-person or online to hear world leading experts discuss 'Tackling #Fungal #Infections: Novel #Immune and #Diagnostic Approaches.' Link to registration in the section below 👇
1
0
14
RT @JoshuaHillMD: via @fredhutch With increasing infectious disease threats plus a growing population of people wit…
0
6
0
RT @IchsGlobal: #ICHSglobal now had country ambassadors to disseminate information about #immunocompromised host information throughout the…
0
3
0
RT @TakaMatsuo_ID: 【The heterogeneous syndrome of non-infectious causes of persistent fever in neutropenic patients with hematologic malign…
0
64
0
RT @RazonableMD: Secondary antiviral prophylaxis after treatment of CMV infection and disease: systematic review and metaanalysis https://…
0
24
0
1
0
1
Thanks @GermHunterMD this is an important paper. Please read. EORTC/MSGERC criteria on host factors, repeat molecular testing , excluded these patients from meeting IA definitions - they have similar high mortality @NCICancer @monicaslavin
0
5
9
Great to be here with @ChemalyRoy @banhocktan - we talk about challenges and controversies in CMV at APBMT. @IchsGlobal @NCICancer
0
2
17
RT @jschaenman: We are so fortunate to host #TxID and infx prevention expert Dr. Priya Garg joining us from Melbourne 🇦🇺 - discussing ma…
0
3
0
RT @TakaMatsuo_ID: 【Chimeric antigen receptor-T-cell therapies going viral: latent and incidental viral infections】Curr Opin Infect Dis, Oc…
0
30
0
@victoriahall26 @NCICancer @kedzierskalab @id_austin @benwteh @options2024 Well done Tori ! This is fabulous work - good to see you back on home turf @options2024 @NCICancer @victoriahall26
0
0
3
RT @victoriahall26: Poster presentations in session… presenting influenza-specific B & T cell analyses in pts w/ haematological malignancy…
0
6
0
RT @syctong: This is well worth a read, I've done so twice so far, if interested in Bayesian statistics for research and clinical trials. V…
0
20
0
RT @AbbyPDouglas: Really looking forward to co-chairing this important and stimulating session! Much to do in the AMS space in ICH, we will…
0
2
0
RT @MichaelGIsonMD: Please join ESGICH for our first session of our Webinar Series on September 24 at 12pm CET/8pm Melbourne/6am EST. This…
0
7
0
RT @DrNeha90356702: My view and quote on Chandipura virus in "The Lancet " vector control, vaccine & surveillance @…
0
3
0
RT @NCICancer: Register now for our hybrid annual Symposium "Tackling Fungal infections" 10am Melbourne, Australia…
0
6
0
RT @TransplantJrnl: Quantiferon mediated CMV assay as a marker for cell mediated immunity to decide the duration of CMV prophylaxis in high…
0
32
0
RT @NCAS_Aus: Infectious diseases got the guernsey for the first @NEJM/@DGlaucomflecken TikTok. Very clever
0
1
0